Cargando…
Medication risks in older patients (70 +) with cancer and their association with therapy-related toxicity
BACKGROUND: To evaluate medication-related risks in older patients with cancer and their association with severe toxicity during antineoplastic therapy. METHODS: This is a secondary analysis of two prospective, single-center observational studies which included patients ≥ 70 years with cancer. The p...
Autores principales: | Ortland, Imke, Mendel Ott, Monique, Kowar, Michael, Sippel, Christoph, Ko, Yon-Dschun, Jacobs, Andreas H., Jaehde, Ulrich |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429305/ https://www.ncbi.nlm.nih.gov/pubmed/36042410 http://dx.doi.org/10.1186/s12877-022-03390-z |
Ejemplares similares
-
Evaluation of patient-reported severity of hand–foot syndrome under capecitabine using a Markov modeling approach
por: Schmulenson, Eduard, et al.
Publicado: (2020) -
Adherence management for patients with cancer taking capecitabine: a prospective two-arm cohort study
por: Krolop, Linda, et al.
Publicado: (2013) -
Developing tumor-specific PRO-CTCAE item sets: analysis of a cross-sectional survey in three German outpatient cancer centers
por: Günther, Maximilian, et al.
Publicado: (2023) -
Influence of the skeletal muscle index on pharmacokinetics and toxicity of fluorouracil
por: Schmulenson, Eduard, et al.
Publicado: (2022) -
Repeated Radionuclide therapy in metastatic paraganglioma leading to the highest reported cumulative activity of (131)I-MIBG
por: Ezziddin, Samer, et al.
Publicado: (2012)